Home LiteratureArticle Details
PMID: 8119308 Published · ppublish English Journal Article

Cromakalim does not protect against skeletal muscle fatigue in an anaesthetized rat model of acute hindlimb ischaemia.

European journal of pharmacology ·Vol. 250 ·No. 1 ·1993-11-30 ·Pages 109-16

Trezise DJ, Drew GM, Roach AG, Watts IS, Weston AH

Abstract

The effects of the potassium (K+) channel opener, cromakalim, on skeletal muscle performance were studied in a model of acute hindlimb ischaemia in the anaesthetized rat. Twitch contractions to direct electrical stimulation of the extensor digitorum and tibialis anterior skeletal muscles were recorded following administration of cromakalim (10-100 micrograms kg-1 i.v.) under normal and reduced whole limb blood flow. With normal blood flow, twitch responses (0.5 and 1 Hz) of the hindlimb skeletal muscles were sustained for > 30 min. Controlled adjustment of the perfusion pressure in the contralateral hindlimb to 45, 30 or 0 mm Hg by partial or total occlusion of the abdominal aorta produced a pressure-related fall in flow to the working hindlimb, and a corresponding increase in the rate of muscle fatigue. Cromakalim (10-100 micrograms kg-1 i.v.) produced a dose-dependent reduction in mean carotid arterial blood pressure, femoral arterial pressure and hindlimb vascular resistance together with an increase in iliac artery blood flow and heart rate, but did not attenuate skeletal muscle fatigue under the different conditions of muscle work and ischaemia employed. A similar profile was observed with levcromakalim (15 micrograms kg-1 i.v.), the active enantiomer of cromakalim. These results demonstrate that in the direct muscle-stimulated hindlimb of the anaesthetized rat, the K+ channel opener cromakalim does not prevent acute ischaemia-induced skeletal muscle fatigue. The previous observation that K+ channel openers improve nutritive blood flow in a chronic model of rat hindlimb ischaemia is not reflected by an improvement in muscle function in the present study.

MeSH Terms
Animals Benzopyrans/administration & dosage,pharmacology,therapeutic use Blood Pressure/drug effects Cromakalim Disease Models, Animal Dose-Response Relationship, Drug Electric Stimulation Heart Rate/drug effects Hindlimb/blood supply Ischemia/drug therapy,physiopathology Male Muscle Contraction/drug effects Muscles/drug effects,physiopathology Pyrroles/administration & dosage,pharmacology,therapeutic use Rats Rats, Sprague-Dawley Regional Blood Flow/drug effects Vasodilator Agents/pharmacology,therapeutic use
Chemicals
Benzopyrans Pyrroles Vasodilator Agents Cromakalim
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Trezise D J
Department of Cardiovascular and Respiratory Pharmacology, Glaxo Group Research Ltd., Ware, Hertfordshire, UK.
Drew G M
Roach A G
Watts I S
Weston A H
Article Info
Journal
European journal of pharmacology
Abbr.
Eur J Pharmacol
ISSN
0014-2999
Published
1993-11-30
Pages
109-16
Language
English
Region
Netherlands
NLM ID
1254354
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com